Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis.
نویسندگان
چکیده
more commonly among men in their 50s. Back pain (19.1%) was the most common rheumatic manifestation. Myalgia (15.5%) was also frequently observed, as was arthra l gia without art h ritis (10%). Pe ri p h e ra l arthritis (13.6%) was also present, but generally as monoarthritis. In contrast, sacroiliitis was only observed in a single patient. This patient was a man in his early twenties, who had positive blood cultures for Entero coccus faecalis, and experienced a progressive improvement of his sacroiliac pain foll owing antibiotic therapy with ampicillin and gentamicin (2). It is worth noting that in our series of patients with IE and rheumatic manifestations m i c ro h e m at u ria was observed in almost 60% of the patients, versus 27% in IE patients without rheumatic manifestations (2). In summary, u n explained peri p h e ral synov i t i s , a rt h ra l gia or low back pain along with unexplained microhematuria may be possible warning signs for the presence of IE. Awareness of these complications may be useful to avoid inappropriate delay in the diagnosis of this severe disease.
منابع مشابه
Macrophage Activation Syndrome as the First Presentation of Juvenile Idiopathic Arthritis
Macrophage activation syndrome (MAS) is a rare feature of rheumatic disorders in children and adolescence and its presentation as the first symptom of rheumatic disorders is very infrequent. A 9-year-old girl, in whom MAS developed, was admitted to our Hospital in Tehran, Iran. She suffered from high grade fever and rash followed by multiple joint swelling months afterwards. Bone marrow aspira...
متن کاملMacrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis
Systemic onset juvenile idiopathic arthritis (sJIA) is defined as arthritis affecting one or more joint usually in the juvenile age group (< 16 years of age) with or preceded by fever of at least 2 weeks duration that is documented to be daily ("quotidian") for at least 3 days which may be associated with evanescent (non-fixed) erythematous rash or generalized lymph node enlargement or hepatome...
متن کاملA case of systemic juvenile idiopathic arthritis with pulmonary hemosiderosis secondary to recurrent macrophage activation syndrome or a new autoinflammatory syndrome?
Introduction Macrophage activation syndrome (MAS), a severe complication of systemic juvenile idiopathic arthritis (JIA) and other inflammatory diseases, represents a one of the most important rheumatological emergencies. Delayed diagnosis could lead to life-threatening complications. Pulmonary hemosiderosis (PH), possible seen at all ages but most commonly among children, usually appears as an...
متن کاملMacrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
Macrophage activation syndrome is a rare and potentially life threatening complication of childhood rheumatic disorders. It is described most commonly with systemic onset juvenile idiopathic arthritis (soJIA). The major clinical manifestations are non-remitting fever, hepatosplenomegaly, lymphadenopathy, bleeding diathesis, altered mental status and rash and may mimic a fl are of soJIA. The cha...
متن کاملMacrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
Introduction Macrophage activation syndrome (MAS) is a severe, potentially fatal complication of systemic juvenile idiopathic arthritis (sJIA). Changes in therapies, including biologics, have been associated with the onset of MAS. Interleukin-6 (IL-6) plays a major pathogenic role in sJIA; data in animals suggest that high IL-6 levels contribute to the triggering of MAS [1]. Treatment with the ...
متن کاملMethotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Macrophage activation syndrome (MAS) is a potentially life threatening complication of chronic rheumatic diseases, particularly systemic juvenile idiopathic arthritis (JIA). A number of triggers have been related to the development of MAS, including viral infections, nonsteroidal antiinflammatory drug therapy, and gold salt injections. We describe a patient with systemic JIA who developed MAS s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical and experimental rheumatology
دوره 19 6 شماره
صفحات -
تاریخ انتشار 2001